miR-31 links lipid metabolism and cell apoptosis in bacteria-challenged Apostichopus japonicus via targeting CTRP9

Frontiers in Immunology

Volumn 8, Issue MAR, 2017, Pages

  Shao, Yina ^a   Li, Chenghua ^a   Xu, Wei ^b   Zhang, Pengjuan ^a   Zhang, Weiwei ^a   Zhao, Xuelin ^a  

^a NINGBO UNIVERSITY   (China)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Apostichopus japonicus; Ceramide; Complement C1q tumor necrosis factor related protein 9; Lipidomics; miR 31

Indexed keywords

ADIPOCYTOKINE; CASPASE; CASPASE 3; CASPASE 8; CERAMIDE; COMPLEMENT C1Q TUMOR NECROSIS FACTOR-RELATED PROTEIN 9; COMPLEMENT COMPONENT C1Q; MESSENGER RNA; MICRORNA 31; NEUTRAL CERAMIDASE; POLYCLONAL ANTIBODY; SERINE PALMITOYLTRANSFERASE; SMALL INTERFERING RNA; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; APOSTICHOPUS JAPONICUS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LUCIFERASE ASSAY; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SPHINGOLIPID METABOLISM; WESTERN BLOTTING;

EID: 85017261799     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00263     Document Type: Article

References (75)

1. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 18:363-74. doi: 10.1038/nm.2627
2. Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev Immunol (2014) 32:609-34. doi:10.1146/annurev-immunol-032713-120236
3. Brestoff JR, Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell (2015) 161(1):146-60. doi:10.1016/j.cell.2015.02.022
4. Im S, Yousef L, Blaschitz C, Liu JZ, Edwards RA, Young SG, et al. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab (2011) 13(5):540-9. doi:10.1016/j.cmet.2011.04.001
5. Huang C, Freter C. Lipid metabolism, apoptosis and cancer therapy. Int J Mol Sci (2015) 16(1):924-49. doi:10.3390/ijms16010924
6. Pizarro-Cerdá J, Cossart P. Subversion of phosphoinositide metabolism by intracellular bacterial pathogens. Nat Cell Biol (2004) 6:1026-33. doi:10.1038/ncb1104-1026
7. Feng D, Tang Y, Kwon H, Zong H, Hawkins M, Kitsis RN, et al. High-fat diet-induced adipocyte cell death occurs through a cyclophilin D intrinsic signaling pathway independent of adipose tissue inflammation. Diabetes (2011) 60(8):2134-43. doi:10.2337/db10-1411
8. Bartel DP. microRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 116(2):281-97. doi:10.1016/S0092-8674(04)00045-5
9. Pasquinelli AE, Ruvkun G. Control of developmental timing by mircoRNAs and their targets. Annu Rev Cell Dev Biol (2002) 18(1):495-513. doi:10.1146/annurev.cellbio.18.012502.105832
10. Yuan Y, Zeng Z, Liu X, Gong DJ, Tao J, Cheng HZ, et al. microRNA-203 inhibits cell proliferation by repressing [Delta]Np63 expression in human esophageal squamous cell carcinoma. BMC Cancer (2011) 11:57. doi:10.1186/1471-2407-11-57
11. Smith AL, Iwanaga R, Drasin DJ, Micalizzi DS, Vartuli RL, Tan AC, et al. The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogene (2012) 31(50):5162-71. doi:10.1038/onc.2012.11
12. Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y, et al. microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. Carcinogenesis (2012) 33(1):220-5. doi:10.1093/carcin/bgr245
13. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res (2008) 79(4):581-8. doi:10.1093/cvr/cvn156
14. Wilfred BR, Wang W, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab (2007) 91:209-17. doi:10.1016/j.ymgme.2007.03.011
15. Flowers E, Froelicher ES, Aouizerat BE. microRNA regulation of lipid metabolism. Metabolism (2012) 62(1):12-20. doi:10.1016/j.metabol.2012.04.009
16. Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S, et al. micro-RNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated monocyte/macrophages. Cardiovasc Res (2009) 83(1):131-9. doi:10.1093/cvr/cvp121
17. Ouimet M, Ediriweera HN, Gundra UM, Sheedy FJ, Ramkhelawon B, Hutchison SB, et al. microRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest (2015) 125(12):4334-48. doi:10.1172/JCI81676
18. Gerin I, Bommer GT, McCoin CS, Sousa KM, Krishnan V, MacDougald OA. Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab (2010) 299(2):E198-206. doi:10.1152/ajpendo.00179.2010
19. Aranda JF, Madrigal-Matute J, Rotllan N, Fernández-Hernando C. microRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic Biol Med (2013) 64:31-9. doi:10.1016/j.freeradbiomed.2013.07.014
20. Xu P, Vernooy SY, Guo M, Hay BA. The Drosophila microRNA miR-14 suppresses cell death and is required for normal fat metabolism. Curr Biol (2003) 13(9):790-5. doi:10.1016/S0960-9822(03)00250-1
21. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al. miR-33 contributes to the regulation of cholesterol homeostasis. Science (2010) 328(5985):1570-3. doi:10.1126/science.1189862
22. Dávalos A, Goedeke L, Smibert P, Ramírez CM, Warrier NP, Andreo U, et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A (2011) 108(22):9232-7. doi:10.1073/pnas.1102281108
23. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. microRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res (2010) 51(6):1513-23. doi:10.1194/jlr.M004812
24. Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, et al. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun (2009) 385(4):492-6. doi:10.1016/j.bbrc.2009.05.058
25. Lee EK, Lee MJ, Abdelmohsen K, Kim W, Kim MM, Srikantan S, et al. miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor ? expression. Mol Cell Biol (2011) 31(4):626-38. doi:10.1128/MCB.00894-10
26. Rotllan N, Price N, Pati P, Goedeke L, Fernández-Hernando C. microRNAs in lipoprotein metabolism and cardiometabolic disorders. Atherosclerosis (2016) 246:352-60. doi:10.1016/j.atherosclerosis.2016.01.025
27. Deng H, He C, Zhou Z, Liu C, Tan K, Wang N, et al. Isolation and pathogenicity of pathogens from skin ulceration disease and viscera ejection syndrome of the sea cucumber Apostichopus japonicus. Aquaculture (2009) 287:18-27. doi:10.1016/j.aquaculture.2008.10.015
28. Liu H, Zheng F, Sun X, Hong X, Dong S, Wang B, et al. Identification of the pathogens associated with skin ulceration and peristome tumescence in cultured sea cucumbers Apostichopus japonicus (Selenka). J Invertebr Pathol (2010) 105(3):236-42. doi:10.1016/j.jip.2010.05.016
29. Li C, Feng W, Qiu L, Xia C, Su X, Jin C, et al. Characterization of skin ulceration syndrome associated microRNAs in sea cucumber Apostichopus japonicus by deep sequencing. Fish Shellfish Immunol (2012) 33(2):436-41. doi:10.1016/j.fsi.2012.04.013
30. Shao Y, Li C, Ou C, Zhang P, Lu Y, Su X, et al. Divergent metabolic responses of Apostichopus japonicus suffered from skin ulceration syndrome and pathogen challenge. J Agric Food Chem (2013) 61(45):10766-71. doi:10.1021/jf4038776
31. Hwang YC, Oh SW, Park SW, Park CY. Association of serum C1q/TNF-related protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Int J Obes (2014) 38(9):1207-12. doi:10.1038/ijo.2013.242
32. Forouh N, Saedisomeolia A, Djalali M, Eshraghian MR, Morshedzadeh N, Zabetian-Targhi F, et al. Serum C1q and tumor necrosis factor (TNF)-related protein 9 in women with polycystic ovary syndrome. Diabetes Metab Syndr (2016) 10:S131-4. doi:10.1016/j.dsx.2016.03.012
33. Zhang P, Li C, Zhu L, Su X, Li Y, Jin C, et al. De novo assembly of the sea cucumber Apostichopus japonicus hemocytes transcriptome to identify miRNA targets associated with skin ulceration syndrome. PLoS One (2013) 8(9):e73506. doi:10.1371/journal.pone.0073506
34. Sun X, Lv Z, Li C, Lu M, Zhang P, Zhang W. Identification and characterization of miR-31 potential targets by RNA-seq. Fish Shellfish Immunol (2016) 51:26-32. doi:10.1016/j.fsi.2016.02.014
35. Xing J, Leung MF, Chia FS. Quantitative analysis of phagocytosis by amebocytes of a sea cucumber. Holothuria Leucospilota Invertebr Biol (1998) 117(1):13-22. doi:10.2307/3226853
36. Gu M, Ma H, Mai K, Zhang W, Ai Q, Wang X, et al. Immune response of sea cucumber Apostichopus japonicus coelomocytes to several immunostimulants in vitro. Aquaculture (2010) 306(1-4):49-56. doi:10.1016/j.aquaculture.2010.05.024
37. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods (2011) 25(4):402-8. doi:10.1006/meth.2001.1262
38. Zhang P, Li C, Zhang R, Zhang W, Jin C, Wang L, et al. The roles of two miRNAs in regulating the immune response of sea cucumber. Genetics (2015) 201(4):1397-410. doi:10.1534/genetics.115.178871
39. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 37(8):911-7. doi:10.1139/o59-099
40. Li S, Xu J, Jiang Y, Zhou C, Yu X, Zhong Y, et al. Lipidomic analysis can distinguish between two morphologically similar strains of Nannochloropsis oceanica. J Phycol (2015) 51(2):264-76. doi:10.1111/jpy.12271
41. Chen D, Yan X, Xu J, Su X, Li L. Lipidomic profiling and discovery of lipid biomarkers in Stephanodiscus sp. under cold stress. Metabolomics (2013) 9:949-59. doi:10.1007/s11306-013-0515-z
42. Li S, Xu J, Chen J, Chen J, Zhou C, Yan X. The major lipid changes of some important diet microalgae during the entire growth phase. Aquaculture (2014) 428-429:104-10. doi:10.1016/j.aquaculture.2014.02.032
43. Vella MC, Reinert K, Slack FJ. Architecture of a validated microRNA: target interaction. Chem Biol (2004) 11(12):1619-23. doi:10.1016/j.chembiol.2004.09.010
44. Huang Y, Qi Y, Ruan Q, Ma Y, He R, Ji Y, et al. A rapid method to screen putative mRNA targets of any known microRNA. Virol J (2011) 8:8. doi:10.1186/1743-422X-8-8
45. Brodersen P, Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol (2009) 10(2):141-8. doi:10.1038/nrm2619
46. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Ge G, Spooner E, Hug C, et al. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J (2009) 23(1):241-58. doi:10.1096/fj.08-114991
47. Peterson JM, Wei Z, Seldin M, Byerly MS, Aja S. CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. Am J Physiol Regul Integr Comp Physiol (2013) 305(5):R522-33. doi:10.1152/ajpregu.00110.2013
48. Wiklund S, Johansson E, Sjösttoöm L, Mellerowicz EJ, Edlund U, Shokcor JP, et al. Visualization of GC/TOF-MS-based metobolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem (2008) 80(1):115-22. doi:10.1021/ac0713510
49. Ogretmen B. Sphingolipids in cancer: regulation of pathogenesis and therapy. FEBS Lett (2006) 580(23):5467-79. doi:10.1016/j.febslet.2006.08.052
50. Shao Y, Li C, Zhang W, Duan X, Li Y, Jin C, et al. Molecular cloning and characterization of four caspases members in Apostichopus japonicu. Fish Shellfish Immunol (2016) 55:203-11. doi:10.1016/j.fsi.2016.05.039
51. Raisch J, Darfeuille-Michaud A, Nguyen HTT. Role of microRNAs in the immune system, inflammation and cancer. World J Gastroenterol (2013) 19(20):2985-96. doi:10.3748/wjg.v19.i20.2985
52. Lu M, Zhang P, Li C, Zhang W, Jin C, Han Q. miR-31 modulates coelomocytes ROS production via targeting p105 in Vibrio splendidus challenged sea cucumber Apostichopus japonicus in vitro and in vivo. Fish Shellfish Immunol (2015) 45(2):293-9. doi:10.1016/j.fsi.2015.04.024
53. Rottiers V, Näär AM. microRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol (2012) 13(4):239-50. doi:10.1038/nrm3313
54. Bartel DP. microRNAs: target recognition and regulatory functions. Cell (2009) 136(2):215-33. doi:10.1016/j.cell.2009.01.002
55. Laurila EM, Kallioniemi A. The diverse role of miR-31 in regulating cancer associated phenotypes. Genes Chromosome Cancer (2013) 52:1103-13. doi:10.1002/gcc.22107
56. Schmittgen TD. miR-31: a master regulator of metastasis? Future Oncol (2010) 6(1):17-20. doi:10.2217/fon.09.150
57. Stepicheva NA, Song JL. Function and regulation of microRNA-31 in development and disease. Mol Reprod Dev (2016) 83(8):654-74. doi:10.1002/mrd.22678
58. Wei Z, Lei X, Petersen PS, Aja S, Wong GW. Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice. Am J Physiol Endocrinol Metab (2014) 306(7):E779-90. doi:10.1152/ajpendo.00593.2013
59. Jung CH, Lee MJ, Kang YM, Lee YL, Seol SM, Yoon HK, et al. C1q/TNF-related protein-9 inhibits cytokine-induced vascular inflammation and leukocyte adhesiveness via AMP-activated protein kinase activation in endothelial cells. Mol Cell Endocrinol (2016) 419:235-43. doi:10.1016/j.mce.2015.10.023
60. Jung TW, Hong HC, Hwang H, Yoo H, Baik S, Choi KM. C1q/TNF-related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress. Mol Cell Endocrinol (2015) 417:131-40. doi:10.1016/j.mce.2015.09.027
61. Kambara T, Shibata R, Ohashi K, Matsuo K, Hiramatsu-Ito M, Enomoto T, et al. C1q/tumor necrosis factor-related protein 9 protects against acute myocardial injury through an adiponectin receptor I-AMPK-dependent mechanism. Mol Cell Biol (2015) 35(12):2173-85. doi:10.1128/MCB.01518-14
62. Zechner R, Zimmermann R, Eichmann TO, Kohlwein SD, Haemmerle G, Lass A, et al. Fat signals-lipases and lipolysis in lipid metabolism and signaling. Cell Metab (2012) 15(3):279-91. doi:10.1016/j.cmet.2011.12.018
63. Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J (2012) 279(15):2610-23. doi:10.1111/j.1742-4658.2012.08644.x
64. Mullen TD, Obeid LM. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer Agents Med Chem (2012) 12(4):340-63. doi:10.2174/187152012800228661
65. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science (1993) 259(5102):1769-71. doi:10.1126/science.8456305
66. Lupi R, Dotta F, Marselli L, Del GS, Masini M, Santangelo C, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes (2002) 51(5):1437-42. doi:10.2337/diabetes.51.5.1437
67. Kroesen BJ, Pettus B, Luberto C, Busman M, Sietsma H, de Leij L, et al. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J Biol Chem (2001) 276(17):13606-14. doi:10.1074/jbc.M009517200
68. Wang S, Hojabrpour P, Zhang P, Kolesnick RN, Steinbrecher UP, Gómez-Muñoz A, et al. Regulation of ceramide generation during macrophage apoptosis by ASMase and de novo synthesis. Biochim Biophys Acta (2015) 1851(11):1482-9. doi:10.1016/j.bbalip.2015.08.002
69. Levy M, Futerman AH. Mammalian ceramide synthases. IUBMB Life (2010) 62(5):347-56. doi:10.1002/iub.319
70. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol (2008) 9(2):139-50. doi:10.1038/nrm2329
71. Ogretmen B, Pettus BJ, Rossi MJ, Wood R, Usta J, Szulc Z, et al. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. J Biol Chem (2002) 277(15):12960-9. doi:10.1074/jbc.M110699200
72. Grether-Beck S, Timmer A, Felsner I, Brenden H, Brammertz D, Krutmann J. Ultraviolet A-induced signaling involves a ceramide-mediated autocrine loop leading to ceramide de novo synthesis. J Invest Dermatol (2000) 125(3):545-53. doi:10.1111/j.0022-202X.2005.23782.x
73. Osawa Y, Uchinami H, Bielawski J, Schwabe RF, Hannun YA, Brenner DA. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-a. J Biol Chem (2005) 280(30):27879-87. doi:10.1074/jbc.M503002200
74. Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci (2007) 32(1):37-43. doi:10.1016/j.tibs.2006.11.001
75. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ (1999) 6(11):1028-42. doi:10.1038/sj.cdd.4400598